Use of a steroid for enhancement of skin permeability

Details for Australian Patent Application No. 2005263551 (hide)

Owner Novartis AG

Inventors Meingassner, Josef Gottfried

Agent Davies Collison Cave

Pub. Number AU-B-2005263551

PCT Pub. Number WO2006/008092

Priority 0415994.3 16.07.04 GB; 0417205.2 02.08.04 GB; 60/605,328 27.08.04 US

Filing date 15 July 2005

Wipo publication date 26 January 2006

Acceptance publication date 9 April 2009

International Classifications

A61K 31/436 (2006.01)

A61K 47/28 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Steroids

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/008092 Priority application(s): WO2006/008092

9 April 2009 Application Accepted

  Published as AU-B-2005263551

6 August 2009 Standard Patent Sealed

10 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005263555-Expression-enhanced polypeptides

2005263550-Oxidative degradation products of atorvastatin calcium